Development of an ophthalmic diagnostic probe for neurodegenerativedisorders
Development of an ophthalmic diagnostic probe for neurodegenerativedisorders
批准号:
9357487
负责人:
Stella Sarraf
金额:
$21.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-30 至 2018-05-31
关键词:
Alzheimer&aposs DiseaseAmyloidAmyloid depositionAmyloidosisAnimalsBindingBrainCadaverClinicClinicalComputer softwareDementiaDepositionDevelopmentDiagnosisDiagnosticDiagnostic ImagingDiagnostic ProcedureDiagnostic testsDiseaseDisease ProgressionDoseEarly DiagnosisEvaluationEyeEye diseasesFamilyFluorescent ProbesFormulationHumanImageImage AnalysisImageryImpaired cognitionIndividualIntravenousKilogramLabelMethodsModelingMonitorMorphologyMusNeuraxisNeurobehavioral ManifestationsNeurodegenerative DisordersNeuronsOptical MethodsOryctolagus cuniculusPathogenesisPathologyPatientsPharmacologic SubstancePhasePrionsProcessPropertyReportingResearchRetinaRetinalSenile PlaquesSignal TransductionSmall Business Innovation Research GrantSodium ChlorideSolidStaining methodStainsSymptomsTechnologyTestingTissuesTopical applicationToxicologyTranslatingTranslationsage relatedamyloid imaginganimal imagingbasebiophysical propertiesclinical applicationclinical developmentcrystallinitydensitydesigndisease diagnosisdrug candidateeffective therapyexperimental studyfluorescence imaginghuman tissuein vivomouse modelnovelphysical propertyprotein aggregateresearch clinical testingsmall moleculetooltool development
中文摘要
项目摘要
淀粉样蛋白斑块在脑中的沉积代表了阿尔茨海默病病理学的普遍特征,
比临床症状早几年目前,淀粉样蛋白相关性痴呆的诊断,
表现出认知能力下降症状的人是非常困难的,需要多种模式的测试,
数月到数年早期,症状前诊断更具挑战性,如果不是不可能的话,目前
现有技术。非常需要一种用于诊断阿尔茨海默病的非侵入性方法。
我们将进一步评估AMDX-201的使用,AMDX-201是一种新型的荧光探针,可以标记组织中的淀粉样蛋白,
作为老年痴呆症的诊断工具AMDX-201已被证明可荧光标记AD相关沉积物
in vivo.重要的是,这种探针也被证明可以有效地对AD患者视网膜中的淀粉样蛋白沉积物进行成像。
局部和静脉给药后的小鼠。AMDX-201的性能是其发展的理想选择
作为AD的局部诊断探针本提案中概述的研究将AMDX-201推进到Pre-IND
阶段AMDX-201的合成将通过专门的工艺开发活动进行优化。一
将沿着开发用于人体局部给药的有效制剂,
在两种动物中的诊断功效。此外,在整个配制过程中获得的视网膜图像
将利用这项研究开发一种方法来量化淀粉样蛋白沉积的数量、大小和强度。
总之,该提案的目的将导致能够在AD中成像的优化诊断产品。
视网膜。该诊断产品将被推进到为IND启用毒理学研究做好准备的程度。
英文摘要
Project Summary
Deposition of amyloid plaques in the brain represents a universal feature Alzheimer’s disease pathology and
precedes clinical symptoms by several years. Currently, diagnosis of amyloid-associated dementias in
individuals showing symptoms of cognitive decline is extremely difficult, requiring multiple modes of testing over
months to years. Early, pre-symptomatic diagnosis is even more challenging, if not impossible, with currently
available technology. A non-invasive method for diagnosing Alzheimer’s disease is greatly needed.
We will further evaluate the use of AMDX-201, a novel fluorescent probe that can label amyloids in tissue,
as a diagnostic for Alzheimer’s disease. AMDX-201 has been shown to fluorescently label AD-related deposits
in vivo. Importantly, this probe has also been shown to effectively image amyloid deposits in the retina of AD-
mice following both topical and intravenous dosing. The properties of AMDX-201 are ideal for its development
as a topical diagnostic probe for AD. The studies outlined in this proposal advance AMDX-201 to the Pre-IND
stage. The synthesis of AMDX-201 will be optimized through dedicated process development activities. A
formulation effective for topical administration in humans will be developed along with in vivo evaluation of
diagnostic efficacy in two species of animals. Further, the retinal images obtained throughout formulation
development will be utilized to develop a method to quantify the number, size and intensity of amyloid deposits.
Together, the aims of this proposal will result in an optimized diagnostic product capable of imaging AD in the
retina. The diagnostic product will be advanced to the point of being ready for IND-enabling Toxicology studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a novel fluorescent tracer for detection of retinal TDP43 in ALS and FTD
-
批准号:10483027
-
项目类别:
-
资助金额:$45.85万
-
财政年份:2022
-
负责人:Stella Sarraf
-
依托单位:
Differential diagnosis of Parkinson's and multiple system atrophy in non-human primate models using a novel a-synuclein retinal contrast agent and AI-assisted analytics
-
批准号:10323567
-
项目类别:
-
资助金额:$207.76万
-
财政年份:2021
-
负责人:Stella Sarraf
-
依托单位:
Development of Novel Tau Retinal Tracers for Alzheimer's Disease and other Tauopathies
-
批准号:10323564
-
项目类别:
-
资助金额:$49.22万
-
财政年份:2021
-
负责人:Stella Sarraf
-
依托单位:
Development of an ophthalmic diagnostic probe for cerebral amyloid angiopathy in patients
-
批准号:10515850
-
项目类别:
-
资助金额:$144.28万
-
财政年份:2021
-
负责人:Stella Sarraf
-
依托单位:
Development of an ophthalmic diagnostic probe for cerebral amyloid angiopathy in patients
-
批准号:10253366
-
项目类别:
-
资助金额:$159.09万
-
财政年份:2021
-
负责人:Stella Sarraf
-
依托单位:
Development of a novel ophthalmic probe for cerebral amyloid angiopathy
-
批准号:10020887
-
项目类别:
-
资助金额:$104.95万
-
财政年份:2017
-
负责人:Stella Sarraf
-
依托单位:
Development of a novel ophthalmic probe for cerebral amyloid angiopathy
-
批准号:9907957
-
项目类别:
-
资助金额:$49.03万
-
财政年份:2017
-
负责人:Stella Sarraf
-
依托单位:
Use of novel fluorescent tracers to develop a comprehensive retinal biomarker database that maps the heterogeneity of Alzheimer's pathogenesis
-
批准号:10821965
-
项目类别:
-
资助金额:$170.44万
-
财政年份:2015
-
负责人:Stella Sarraf
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: